FUESMEN

What FUESMEN does

FUESMEN is a private foundation headquartered in Mendoza, Argentina, focused on nuclear medicine. Founded in 1991, the organization employs between 101 and 250 people and operates in the medical and health sciences domain, with the primary descriptor characterizing it as a school of nuclear medicine. As a foundation with for-profit classification, FUESMEN likely combines educational, clinical, and research activities related to nuclear medicine — a specialized field encompassing diagnostic imaging, radiotherapy, and radiopharmacy.

The organization's business model is not documented in the source data. No pricing models, revenue mechanisms, customer segments, distribution channels, or product/service details are available. No partnerships, certifications, funding rounds, or management team information were extracted. The company's website (fuesmen.edu.ar) returned only a default Apache2 Debian server page at the time of data collection, indicating either a server configuration issue or that the institutional web presence was not publicly accessible during extraction. This data gap materially limits visibility into FUESMEN's actual operations, service lines, and commercial structure.

Based on available firmographics, FUESMEN has been in continuous operation for over three decades, suggesting institutional stability and accumulated domain expertise in a highly regulated medical sub-specialty. Its geographic concentration in Mendoza — a mid-sized Argentine provincial capital — implies a regional rather than national or international service footprint, though no explicit operating geography data was provided. All assessments beyond basic firmographics should be treated as low-confidence given the absence of corroborating operational data.

Name

FUESMEN

Legal name

FUESMEN

Website

https://fuesmen.edu.ar

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

51–100 employees

Short description

FUESMEN is a private nuclear medicine foundation founded in 1991 in Mendoza, Argentina, employing 101-250 people. It operates as an educational and medical institution focused on the nuclear medicine discipline, serving regional healthcare and academic needs.

Ownership category

akta.pro rank

Product category

Nuclear Medicine Services

NAICS

Colleges, Universities, and Professional Schools (6113)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.) (EUAKAIAA)

akta.pro secondary industries

Radioisotope Production (Reactor/Cyclotron/Gamma) (HLAIAGAD), Nuclear Medicine Imaging Tracers & PET/SPECT Supply Chain (FDG, Ga-68, logistics/cold chain) (EUAKAIAE), Quality Assurance Programs & Nuclear Quality Standards (ASME NQA-1, ISO 9001, IAEA) (EUAKAEAC)

Keywords

• Nuclear medicine
• Medical diagnostics
• Healthcare education
• Radiology imaging
• Medical foundation

Headquarters

HQ city

Mendoza

HQ country

Argentina

HQ region

Latin America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations

Core offering

FUESMEN operates as a school and foundation of nuclear medicine, providing education and services related to nuclear medicine in Mendoza, Argentina. Founded in 1991, it is a private organization with 101-250 employees whose publicly accessible web content is currently unavailable, limiting detailed product/service enumeration.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• GE HealthCare: Major manufacturer of PET/CT, SPECT/CT, and cyclotron systems used by FUESMEN and every nuclear medicine center. GE HealthCare is comparable as both a likely equipment vendor to FUESMEN and as an integrated player offering imaging agents (e.g., Vizamyl, DaTscan) through its pharmaceutical diagnostics business.
• Siemens Healthineers: Global supplier of PET/CT, SPECT, and cyclotron systems widely used in nuclear medicine centers. Comparable to FUESMEN as a likely equipment and software partner, and increasingly relevant as Siemens expands into molecular imaging therapeutics and theranostics workflow.
• Lantheus Holdings: US-based radiopharmaceutical company specializing in diagnostic imaging agents (including SPECT and PET tracers such as PyL™/Pylarify). Lantheus is a relevant peer because it competes in the same nuclear medicine imaging supply chain that FUESMEN participates in, particularly for prostate cancer and oncology tracers.
• PETNET Solutions (a Siemens Healthineers company): Operates a global network of cyclotron-based PET radiopharmacies producing FDG and other tracers for hospitals. PETNET is a direct comparator to FUESMEN's clinical PET tracer supply role and represents the kind of scaled, multi-site commercial model FUESMEN could either compete with or partner into.
• Curium Pharma: One of the world's largest nuclear medicine companies, manufacturing and distributing SPECT and PET radiopharmaceuticals globally. Curium represents the scaled commercial counterpart to FUESMEN's isotope production and PET/SPECT tracer activities, and competes for downstream hospital and clinic relationships.
• Bracco Imaging: Italy-based diagnostic imaging company with a significant radiopharmaceutical and contrast agent portfolio (including CardioGen-82, Xenon Xe 133). Bracco is comparable to FUESMEN as a peer in the production and supply of medical isotopes and imaging agents used in nuclear medicine workflows.

Direct peers

• Comisión Nacional de Energía Atómica (CNEA): Argentina's national atomic energy commission and one of FUESMEN's three governing entities. CNEA operates research reactors and isotope production facilities (including Mo-99 supply) that overlap directly with FUESMEN's medical radioisotope mission and shares its public-sector, education-and-research orientation.
• ANSTO (Australian Nuclear Science and Technology Organisation): Australian government nuclear science organization that produces medical radioisotopes (Mo-99, Tc-99m, Lu-177) and operates nuclear medicine research and training programs. ANSTO is a strong international analog to FUESMEN as a publicly-supported, multi-mission (research, isotope production, training) nuclear medicine institution.
• INVAP: Argentine state-owned nuclear technology company that designs and builds reactors and radioisotope production facilities, including those serving nuclear medicine. INVAP supplies much of the underlying infrastructure (research reactors, cyclotrons) that FUESMEN uses, and is the closest domestic comparable for Argentina's nuclear technology ecosystem.

Regional players

• IBAM (Instituto de Biofísica e Biomatemática / nuclear medicine institutions in Brazil): IPEN/CNEN in Brazil is the largest nuclear medicine research and radioisotope production complex in Latin America, operating reactors and cyclotrons producing Mo-99, I-131, and other medical isotopes. It is a regional peer and potential competitor/partner for FUESMEN in supplying Latin American hospitals with medical radioisotopes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/fuesmen
• Facebookfacebook.com/fuesmen
• LinkedInlinkedin.com/company/fuesmen

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FUESMEN